Contexts: An evidence base for CAM consumption within general populations is emerging. However, research data on CAM use for headache disorders remains poorly documented. This paper, constituting the first critical review of literature on this topic, provides a synopsis and evaluation of the research findings on CAM use amongst patients with headache and migraine.
with estimates typically in the range of 1.4-2.2% of the general population. 15 The impact of headache disorders is substantial and the World Health Organization ranks headache disorders as some of the most disabling conditions for both men and women. 14 Given the substantial effect of headache and migraine on the quality of life of the sufferer and the significant disruption to work, family and social duties [16] [17] [18] it is imperative that all effective headache and migraine treatments be explored and researched.
Conventional medical intervention for headache and migraine often involves pharmacological treatment. Acetaminophen (paracetamol), acetylsalicylic acid (aspirin), dipyrone, derivatives of ergot fungus, chlorpromazine, triptans (Imitrex/Imigran et al.), and non-steroidal anti-inflammatories are the most commonly prescribed drugs for the acute treatment of headache and migraine. 19 Tricylic anti-depressants, beta-blockers and anti-epilepsy drugs are the most commonly prescribed and best evidence based classes of pharmacologic preventative interventions for episodic migraine. 20 Despite many patients reporting benefits from these drug treatments, the pharmacological interventions are not without their limitations or side-effects. For instance, amitriptyline, one of the most widely used preventive antimigraine agents, has side-effects ranging from drowsiness, dry mouth, constipation and weight gain to the possibility of precipitating cardiac arrhythmias, seizures or exacerbating closed angle glaucoma. 19 In addition, headache and migraine are often long term with relapses and remissions that create continuing distress and disruption to patients' daily lives. 16 The treatment of headache and migraine is one area of health care where CAM treatment shows some promise. [21] [22] [23] [24] [25] [26] [27] [28] Nevertheless, the benefits and risks of CAM in treating and managing headache and migraine disorders remain contested and a recent systematic assessment of the evidence base of CAM treatment for primary headache found that the overall quality of research of CAM approaches still lags behind studies of conventional medical approaches to primary headache. 29 Results from large cohort/population studies suggest that CAM use is common among headache and migraine patients. For instance, a United States (US) study on symptoms and conditions among CAM users in a large military cohort (n=86, 131) suggested that about 10% of the respondents reported the problem of migraine headache and the study suggested this condition is more likely to be reported by CAM users than by people not using CAM. 30 Analysis of the US National Health Interview Survey (n=31,044) also identified headache as one of the most common health problems experienced by CAM users. 31 While these studies highlight a relationship between CAM use and headache disorders, they provided little information on the patterns of and motivations for CAM use among people with headache and migraine.
Although evidence of CAM use for headache and migraine is emerging, there has been no review or synthesis of CAM user characteristics, perceptions or motivations amongst headache and migraine sufferers. Such a review is essential in order to provide important insights for health practitioners and policymakers with regards to the safety and continuity of care for patients -an issue pronounced by the fact that CAM users appear not to disclose such use to their conventional doctors, Previous studies reveal that a lack of GP interest in their patients' use of CAM or the patients' perception that CAM use is not an important issue that should be raised with their doctor are the two major factors contributing to nondisclosure of CAM. [32] [33] [34] In 6 response, this paper provides the first synopsis and evaluation of the research findings on CAM use amongst patients with headache and migraine as identified from recent international empirical literature. Specifically, this paper aims to: 1) identify the relevant studies that examine the use of CAM among people with headaches; 2) analyse the quality of these studies; and 3) summarise the key findings from these studies using theme-based analysis.
Methods

Design
The aim of the review is to examine the current prevalence, pattern and details of To ensure all relevant international literature was identified, the authors also conducted hand searches in prominent headache and migraine journals including Those papers identified as individual case reports or CAM clinical trials were excluded from the review. In those circumstances where the abstract was deemed to not provide sufficient information, the full article was retrieved and examined prior to a final decision regarding inclusion or exclusion status.
Search Outcomes
The initial search identified 565 papers and a total of fourteen articles met the selection criteria. Two of these fourteen articles 36 37 were subsequently eliminated due to reporting the findings of surveys which were already covered elsewhere. 38 39 As a result, a total of twelve papers were included in this review. Figure 1 reports the literature search process and Table 1 summarizes the basic details of the included papers. 
Quality Appraisal
In order to appraise the quality of the papers identified for review, the authors employed a quality scoring system (Table 2 ) drawing upon quality assessment tools previously used for assessing prevalence studies on low-back pain 50 and CAM use amongst cancer patients. 51 52 The use of these established analytical tools allowed for systematic comparison and evaluation of the CAM surveys reviewed. 51 52 Two authors assigned scores to the studies separately, the results were then compared and disagreements and differences resolved by discussion. Table 3 reports the quality score of each individual study. 
CAM Use
Gaul et al.
Kozak et al.
Lambert et al.
Rossi et al. CAM use' does not apply to these four studies and they were not assessed via the quality scoring system above.
Results
The context and findings of the twelve papers were extracted, grouped and summarized using an integrative review approach. 53 54 The data extracted were synthesized using the following themes: the prevalence of CAM use, user profile and predictors of use, motivation and perception of CAM use, and referral and disclosure of CAM use.
The Prevalence of CAM Use
The twelve papers selected for review reported a wide range of prevalence rates for CAM use among people with headache and migraine (refer to Table   1 ). For instance, an analysis of national health survey data identified 50% of US adults with migraines or severe headaches as using at least one CAM over the past 12 month period. 39 A similar analysis in Canada discovered that 19%
of people with migraine visited a CAM practitioner in the last 12 months. 43 A large cross-sectional cohort study among patients of tertiary headache centers in Austria and Germany found that 82% of the respondents had used CAM at some stage in their lifetime. 38 Three studies conducted in Italy on patients with different types of headache disorders reported CAM use rates of 31%
(amongst patients with migraine), 40% (amongst patients with chronic tension-type headaches) and 29% (amongst patients with cluster headaches). [44] [45] [46] Meanwhile, another survey of adults in Croatia identified 28% of respondents with headache disorders had used CAM (lifetime prevalence). 49 Despite these variations in findings, the studies do indicate Acupuncture, massage, chiropractic and homeopathy were the most common therapies reported as used by those suffering from headache and migraine in the studies reviewed. The findings of a large national representative survey suggested that mind-body therapies such as meditation, breathing exercise and yoga were the most common CAM used by US respondents with migraines or severe headaches. 39 There is evidence that a majority of CAM users seek CAM concurrent with (ranged from 7% to 30%) or following (ranged from 64% to 93%) a GP visit. 42 44-46 In contrast, only a small proportion of respondents (ranging from 5% to 19%) used CAM before they visited a doctor. 42 44-46 . Lambert et al. 42 also found that 80% of their study respondents did not relinquish their use of prescribed medications while consuming CAM. Together these results suggest that CAM is likely used as a complementary (alongside) rather than an alternative treatment (as a replacement) to conventional medicine among people with headache and migraine.
CAM User Profile and Predictors of CAM Use
The socio-demographic characteristics of headache and migraine sufferers who use CAM are similar to the profile of CAM users identified in the general population. 9 12 Specifically, people with headache and migraine who use CAM are more likely to be female, 38 The most common reasons for CAM use as identified by Gaul et al. 38 were 'to leave nothing undone' (64%) and 'to be active against the disease' (56% 
Motivations for and Perceptions of CAM Use
59% -ineffective
Referral:
41% -friends/relatives 34% -GP 25% -Self-recommendation
Disclosure:
40% -disclosed to GP 60% -did not disclose to GP Previous study findings indicate that perceptions of CAM effectiveness are mixed among headache and migraine patients who are CAM users. Lambert et al. 42 explain that 60% of respondents report CAM as reducing/greatly reducing their headache and 58% were satisfied with the therapy used. Von
Peter et al. 48 also found that 60% of the headache patient population interviewed perceived CAM as of potential benefit for the treatment and relief of headache.
However, the three surveys conducted by Rossi et al. [44] [45] [46] reveal that over half of respondents (ranging from 57% to 59%) experienced CAM as ineffective in the treatment of their headache disorders and this was particularly the case among those with migraine (73.1% reporting CAM as being ineffective). 44 In addition, about 5% of respondents in two of these Italian studies reported CAM treatment as resulting in a deterioration of their condition. 44 46 Finally, Vukovic et al. 49 report that satisfaction with CAM varied among patients suffering from different kinds of headache conditions, with 39% of patients with migraine, 60% of patients with tension-type headache, and 41% of patients with probable migraine and tension-type headache reporting satisfaction with their CAM treatment.
Referral to and Disclosure of CAM Use
A review of the research literature identifies three key sources utilised by people with headache and migraine to gain information about CAM. A substantial proportion of headache and migraine patients using CAM (ranging from 41% to 72%) obtain information about CAM from their acquaintances or relatives. 42 44-46 The patients' doctor or nurse was the second common referral source through which headache and migraine patients became familiar with CAM (ranging from 16% to 34%) and a relatively small proportion of headache and migraine patients (ranging from 4% to 20%) relied solely upon their own judgement with regards to using these treatments. 42 44-46 In line with findings from studies of general CAM users, 32 headache and migraine patients utilising CAM do not commonly inform their doctor or nurse about such CAM use. Wells et al. 39 discovered that although CAM users with migraine or headache had a higher disclosure rate than those without migraine or headache, less than half (47%) discuss their CAM use with their conventional healthcare provider(s). The three surveys conducted in Italy by
Rossi et al. [44] [45] [46] identify over 60% of respondents as failing to disclose their CAM use to their conventional doctor. Meanwhile, Soon et al. 47 reveal that only 16% of headache and migraine patients in Singapore using CAM informed their doctor or specialist about such use.
In contrast, Lambert et al., 42 examining headache and migraine patients in the UK, report 58% of their respondents as disclosing CAM use to their doctor or nurse. However, the same survey also discovered that 80% of respondents report their doctor or nurse as never enquiring or initiating discussion with them about CAM use. Rossi et al. 44 also questioned their respondents about their reasons for failing to inform conventional doctors about their CAM use.
In response, 37% of the migraine patients reported that their doctors never ask for this information and 50% of them considered CAM use as a matter either 'not important for the doctor to know' or 'none of the doctor's business'.
Discussion
This paper provides the first critical, comprehensive review of the evidence base of CAM use and users among people suffering from headache and migraine. The use of CAM among patients with headache and migraine is an issue that has increasingly attracted the attention of practitioners and researchers over the past decade 28 55 56 as reflected by the review findings with the bulk of empirical studies (ten out of the twelve studies identified over the last 11 years) having been published since 2005.
Although the evidence base focused upon CAM use among headache and migraine patients has begun to emerge, the ability of this review to generalise from studies or compare findings across studies remains difficult with variations in research design and the definition of CAM employed between studies of particular challenge. This is a problem that also plagues the assessment of clinical outcomes of CAM therapies on treating primary headache. 29 In addition, this review is confined to English language publications and the omission of non-English materials may introduce some bias.
Despite these limitations, the evidence identified and examined in this review does, nevertheless, suggest a substantial level of CAM use among people with headache and migraine. There is also evidence of many headache and migraine sufferers using CAM concurrent to their conventional medicine use (as a complement rather than alternative), a finding consistent with survey results of CAM use in the broader general population. 9 57 The frequent use of a range of CAM amongst people with headache and migraine warrants further investigation. There is evidence that many people use CAM as a follow-up treatment or last resort in an attempt to relieve their headache and migraine symptoms. In contrast, recent findings of a large national health survey indicate that only a small proportion of people with migraines and severe headaches use CAM specifically for the treatment of their headache conditions. 39 The co-existence of a high CAM usage with the fact that a substantial proportion of users consider CAM ineffective in treating their headache symptoms is also interesting. [44] [45] [46] In short, the role of CAM in treating headache and migraine symptoms or helping patients to cope with their distress in their everyday lives remains unclear. There is a need for further in-depth qualitative studies on the motivations, experiences and perceptions of CAM use amongst headache and migraine sufferers.
The prevalence of CAM use amongst headache and migraine patients also has implications for conventional health care providers. Since the prevalence rate of CAM is high amongst headache and migraine patients and a substantial percentage of these patients appear to not disclose their CAM use to conventional practitioners, healthcare professionals should be prepared to enquire and discuss with their patients about possible CAM use. Relevant healthcare providers should also pay attention to the possible adverse effects of CAM or interactions between CAM and conventional medical treatments amongst headache and migraine patients. This is important given a very small minority of headache and migraine patients who utilize CAM report deterioration in their condition. 44 46 In light of this review it is possible to identify areas for future research attention pertaining to headache and migraine patients and CAM use. As the quality scores reported in Table 3 Neurology and the American Headache Society. 20 As the evidence-base demonstrates, the use and satisfaction with CAM varies among patients suffering from different kinds of headache and migraine. 49 Future research will benefit from differentiating and/or targeting patients suffering from different and specific types or severities of headache and migraine. Together, these design features will strengthen the evidence base of CAM use on this topic and provide a much better picture of CAM consumption for the treatment of headache and migraine.
Conclusion
The use of CAM appears to constitute a treatment option considered and employed by a substantial proportion of patients suffering from headache and migraine. This review has provided essential insights into the prevalence and details of CAM use and related issues amongst headache and migraine patients with implications for practitioners (both conventional and CAM) and health policy-makers. It is recommended that further research utilizing both quantitative and qualitative methods be undertaken to address a number of important issues still requiring attention and essential to helping a range of stakeholders provide effective, safe and responsive care and services for those suffering from headache and migraine.
